In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trial

Matshediso C Mokoka, Lorna Lombard, Elaine M MacHale, Joanne Walsh, Breda Cushen, Imran Sulaiman, Damien Mc Carthy, Fiona Boland, Frank Doyle, Eoin Hunt, Desmond M Murphy, John Faul, Marcus Butler, Kathy Hetherington, J Mark FitzGerald, Job Fm van Boven, Liam G Heaney, Richard B Reilly, Richard W Costello, Matshediso C Mokoka, Lorna Lombard, Elaine M MacHale, Joanne Walsh, Breda Cushen, Imran Sulaiman, Damien Mc Carthy, Fiona Boland, Frank Doyle, Eoin Hunt, Desmond M Murphy, John Faul, Marcus Butler, Kathy Hetherington, J Mark FitzGerald, Job Fm van Boven, Liam G Heaney, Richard B Reilly, Richard W Costello

Abstract

Introduction: Many patients with asthma remain poorly controlled despite the use of inhaled corticosteroids and long-acting beta agonists. Poor control may arise from inadequate adherence, incorrect inhaler technique or because the condition is refractory. Without having an objective assessment of adherence, clinicians may inadvertently add extra medication instead of addressing adherence. This study aims to assess if incorporating objectively recorded adherence from the Inhaler Compliance Assessment (INCA) device and lung function into clinical decision making provides more cost-effective prescribing and improves outcomes.

Methods and analysis: This prospective, randomised, multicentre study will compare the impact of using information on adherence to influence asthma treatment. Patients with severe uncontrolled asthma will be included. Data on adherence, inhaler technique and electronically recorded peak expiratory flow rate will be used to promote adherence and guide a clinical decision protocol to guide management in the active group. The control group will receive standard inhaler and adherence education. Medications will be adjusted using a protocol based on Global Initiativefor Asthma (GINA) recommendations. The primary outcome is the between-group difference in the proportion of patients who have refractory disease and are prescribed appropriate medications at the end of 32 weeks. A co-primary outcome is the difference between groups in the rate of adherence to salmeterol/fluticasone inhaler over the last 12 weeks. Secondary outcomes include changes in symptoms, lung function, type-2 cytokine biomarkers and clinical outcomes between both groups. Cost-effectiveness and cost-utility analyses of the INCA device intervention will be performed. The economic impact of a national implementation of the INCA-SUN programme will be evaluated.

Ethics and dissemination: The results of the study will be published as a manuscript in peer-reviewed journals. The study has been approved by the ethics committees in the five participating hospitals.

Trial registration: NCT02307669; Pre-results.

Keywords: INCA electronic monitor; adherence; inhaler technique.; randomisedcontrolled trial; severe uncontrolled asthma.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
The study flow. Phase I of the study involves patient education and development of goals; phase II involves physician–patient review focusing on implementing management changes based on these goals and the patient’s clinical course. GINA, Global Initiative for Asthma; INCA, Inhaler Compliance Assessment.

References

    1. Murphy AC, Proeschal A, Brightling CE, et al. . The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012;67:751–3. 10.1136/thoraxjnl-2011-201096
    1. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30 Suppl 1:2–5. 10.1046/j.1365-2222.2000.00088.x
    1. Bateman ED, Hurd SS, Barnes PJ, et al. . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143–78. 10.1183/09031936.00138707
    1. Holmes MS, Le Menn M, D'Arcy S, et al. . Automatic identification and accurate temporal detection of inhalations in asthma inhaler recordings 2012 Conference proceedings: Annual international conference of the ieee engineering in medicine and biology society ieee engineering in medicine and biology society annual conference, 2012:2595–8.
    1. Holmes MS, Seheult JN, Geraghty C, et al. . A method of estimating inspiratory flow rate and volume from an inhaler using acoustic measurements. Physiol Meas 2013;34:903–14. 10.1088/0967-3334/34/8/903
    1. D'Arcy S, MacHale E, Seheult J, et al. . A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS One 2014;9:e98701 10.1371/journal.pone.0098701
    1. Seheult JN, O'Connell P, Tee KC, et al. . The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhaler. Pharm Res 2014;31:2735–47. 10.1007/s11095-014-1371-x
    1. Holmes MS, Seheult JN, O'Connell P, et al. . An acoustic-based method to detect and quantify the effect of exhalation into a dry powder inhaler. J Aerosol Med Pulm Drug Deliv 2015;28:247–53. 10.1089/jamp.2014.1169
    1. van Boven JF, Trappenburg JC, van der Molen T, et al. . Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med 2015;25:15046 10.1038/npjpcrm.2015.46
    1. Sulaiman I, Seheult J, MacHale E, et al. . A method to calculate adherence to inhaled therapy that reflects the changes in clinical features of asthma. Ann Am Thorac Soc 2016;13:1894–903. 10.1513/AnnalsATS.201603-222OC
    1. Sulaiman I, Seheult J, Killane I, et al. . A new clinically relevant method of calculating adherence. Eur Respir J 2015;46(suppl 59).
    1. Sulaiman I, Seheult J, MacHale E, et al. . Irregular and ineffective: A quantitative observational study of the time and technique of inhaler use. J Allergy Clin Immunol Pract 2016;4:900–9. 10.1016/j.jaip.2016.07.009
    1. O'Dwyer SM, MacHale E, Sulaiman I, et al. . The effect of providing feedback on inhaler technique and adherence from an electronic audio recording device, INCA®, in a community pharmacy setting: study protocol for a randomised controlled trial. Trials 2016;17:226 10.1186/s13063-016-1362-9
    1. Sulaiman I, Mac Hale E, Holmes M, et al. . A protocol for a randomised clinical trial of the effect of providing feedback on inhaler technique and adherence from an electronic device in patients with poorly controlled severe asthma. BMJ Open 2016;6:e009350 10.1136/bmjopen-2015-009350
    1. Sulaiman IM, Seheult E, D'Arcy J, et al. . Inhaler Compliance Assessment (INCA) in an Astma Cohort. Ir J Med Sci 2015;184:S520.
    1. Pavord ID, Brightling CE, Woltmann G, et al. . Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353:2213–4. 10.1016/S0140-6736(99)01813-9
    1. Woodruff PG, Modrek B, Choy DF, et al. . T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388–95. 10.1164/rccm.200903-0392OC
    1. Baines KJ, Simpson JL, Wood LG, et al. . Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011;127:153–60. 10.1016/j.jaci.2010.10.024
    1. McGrath KW, Icitovic N, Boushey HA, et al. . A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012;185:612–9. 10.1164/rccm.201109-1640OC
    1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention LuAfwgo. (accessed 26 May).
    1. Sulaiman I, Cushen B, Greene G, et al. . Objective Assessment of adherence to inhalers by COPD Patients. Am J Respir Crit Care Med 2016.
    1. Holmes MS, Seheult JN, Geraghty C, et al. . A method of estimating inspiratory flow rate and volume from an inhaler using acoustic measurements. Physiol Meas 2013;34:903–14. 10.1088/0967-3334/34/8/903
    1. Seheult JN, O'Connell P, Tee KC, et al. . The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhaler. Pharm Res 2014;31:2735–47. 10.1007/s11095-014-1371-x
    1. Seheult JN, Costello S, Tee KC, et al. . Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study. Springerplus 2014;3:496 10.1186/2193-1801-3-496
    1. Heaney LG, Djukanovic R, Woodcock A, et al. . Research in progress: medical research council united kingdom refractory asthma stratification programme (RASP-UK). Thorax 2016;71:187–9. 10.1136/thoraxjnl-2015-207326
    1. Mac Hale E. INCA training video. 2015, .
    1. Bateman ED, Boushey HA, Bousquet J, et al. . Can guideline-defined asthma control be achieved? the Gaining optimal asthma ControL study. Am J Respir Crit Care Med 2004;170:836–44 10.1164/rccm.200401-033OC
    1. Costello RW, Jacoby DB, Gleich GJ, et al. . Eosinophils and airway nerves in asthma. Histol Histopathol 2000;15:861–8.
    1. Kingham PJ, Costello RW, McLean WG. Eosinophil and airway nerve interactions. Pulm Pharmacol Ther 2003;16:9–13. 10.1016/S1094-5539(02)00093-7
    1. Sheahan P, Walsh RM, Walsh MA, et al. . Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves. Clin Exp Allergy 2005;35:45–51. 10.1111/j.1365-2222.2004.02131.x
    1. Evans CM, Belmonte KE, Costello RW, et al. . Substance P-induced airway hyperreactivity is mediated by neuronal M(2) receptor dysfunction. Am J Physiol Lung Cell Mol Physiol 2000;279:L477–86.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner